12-ID-195: A randomized, double-blind, multicenter Phase II trial to compare the immunogenicity and safety of a liquid frozen and a freeze-dried formulation of IMVAMUNE# (MVABN #) smallpox vaccine in vaccinia-na#ve healthy subjects (POX-MVA-027)

Grants and Contracts Details

StatusFinished
Effective start/end date3/12/13 → 2/28/17

Funding

  • Bavarian Nordic: $829,231.00